Your browser doesn't support javascript.
loading
Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab.
Saarela, Mika; Senthil, Keerthi; Jones, Joanne; Tienari, Pentti J; Soilu-Hänninen, Merja; Airas, Laura; Coles, Alasdair; Saarinen, Jukka T.
Afiliación
  • Saarela M; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Senthil K; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Jones J; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Tienari PJ; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Soilu-Hänninen M; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Airas L; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Coles A; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
  • Saarinen JT; From the Department of Neurology (M.S., P.J.T.), Helsinki University Hospital; Division of Clinical Neurosciences (M.S.-H., L.A.), Turku University Hospital, Finland; Department of Neurology (K.S., J.J., A.C.), Addenbrookes Hospital, University of Cambridge, UK; and Department of Neurology (J.T.S.),
Neurology ; 90(18): 849-851, 2018 05 01.
Article en En | MEDLINE | ID: mdl-29602914
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Linfohistiocitosis Hemofagocítica / Alemtuzumab / Factores Inmunológicos Límite: Adult / Female / Humans / Male Idioma: En Revista: Neurology Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Recurrente-Remitente / Linfohistiocitosis Hemofagocítica / Alemtuzumab / Factores Inmunológicos Límite: Adult / Female / Humans / Male Idioma: En Revista: Neurology Año: 2018 Tipo del documento: Article